Related Experiment Video
Updated: Jul 13, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Dyslipidemia in the metabolic syndrome in children
1A. I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19899, USA. sgidding@nemours.org
Abstract:
The high triglyceride/low high-density lipoprotein cholesterol phenotype is a component of the metabolic syndrome. The obesity epidemic has increased the prevalence of this abnormality. Recognition of this dyslipidemia is increasingly common in pediatric practice. Treatment includes weight management, including the prevention of future excess weight gain, and exercise. Pharmacologic management is rarely required.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Lipid-Lowering Drugs: Statins and Miscellaneous Agents